A, C., JA, P., MN, R., JV, Z., C, C., B, B., . . . MB, H. (2023). Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers. Journal of medicinal chemistry, 66(15), 10289. https://doi.org/10.1021/acs.jmedchem.3c00377
Chicago Style (17th ed.) CitationA, Corlett, et al. "Development of Highly Potent Clinical Candidates for Theranostic Applications Against Cholecystokinin-2 Receptor Positive Cancers." Journal of Medicinal Chemistry 66, no. 15 (2023): 10289. https://doi.org/10.1021/acs.jmedchem.3c00377.
MLA (9th ed.) CitationA, Corlett, et al. "Development of Highly Potent Clinical Candidates for Theranostic Applications Against Cholecystokinin-2 Receptor Positive Cancers." Journal of Medicinal Chemistry, vol. 66, no. 15, 2023, p. 10289, https://doi.org/10.1021/acs.jmedchem.3c00377.